-
As drug shortages swell, FDA seeks more clarity from manufacturers
During dozens of drug shortages, which include cancer medications, emergency treatments and 14 others after a U.S. pharma company closed, the FDA drafted a guidance asking manufacturers to alert the agency on drug supply disruptions. -
California can't be 'done' with Walgreens, experts say
California is legally required to continue doing business with Walgreens through its Medicaid program, legal experts told KHN in an April 6 report. -
Washington state governor purchases 3-year supply of abortion drug
While the nation awaits a decision out of a Texas court that could drastically shape access to medication abortion nationwide, Gov. Jay Inslee of Washington decided to buy a three-year supply of mifepristone, one of two drugs used in medication abortion. -
2 Missouri schools team up to shave 1 year off PharmD program
Webster University, based in Webster Groves, Mo., and the University of Health Sciences and Pharmacy in St. Louis agreed April 3 to meld a school year for students working toward their Bachelor of Science and Doctor of Pharmacy degrees. -
Prominent Illinois hospital pharmacist dies at 85
A prominent Illinois hospital pharmacist, Sister Mary Louise Degenhart, died March 31 at age 85, according to the Belleville Messenger. -
FDA authorizes new COVID-19 drug
The FDA authorized Gohibic (vilobelimab) for emergency use as a COVID-19 treatment for some hospitalized adults. -
Cuban's pharmacy picks up J&J brand-name drugs
Mark Cuban Cost Plus Drug Co. now sells more brand-name drugs. -
2 Georgia schools sign priority applicant deal for PharmD program
Mercer University College of Pharmacy and Georgia Gwinnett College recently inked an agreement for Gwinnett students to have priority applicant status for Mercer's doctor of pharmacy program. -
Mark Cuban's online pharmacy collaborates with Zócalo Health
Mark Cuban Cost Plus Drug Co. will collaborate with Zócalo Health, a healthcare company that focuses on Latino patients, according to a news release shared with Becker's. -
Akorn: From financial troubles to a shutdown and intensifying drug shortages
It has been about a month since a U.S. drugmaker closed all operations, and since then, at least 14 drugs have gone into shortage and four are discontinued. -
Ozempic's No. 1 competitor could upend its success
While droves of patients experiencing obesity have turned to Novo Nordisk's Ozempic for treatment, the drug Mounjaro from its competitor Eli Lilly is closely trailing its success, according to an April 3 report from The Wall Street Journal. -
UCHealth aims to remove language barriers in prescription medications
Medication literacy and patient-centered labels have been linked to improved health outcomes. Now, Denver-based UCHealth has announced plans to take this a step further by implementing a program to translate prescription instructions into 26 languages. -
New York launches Medicaid pharmacy benefit program
New York state aims to increase access to affordable prescription medications through its new pharmacy benefit program, which launched April 1. -
5 weeks later, Akorn's closure racks up 14 swelling drug shortages
Some drug shortages have worsened because of the closure of Gurnee, Ill.-based Akorn Operating Co., according to the American Society of Health-System Pharmacists. -
Pharmacy workers are more burnt out
As the healthcare workforce struggles with burnout, pharmacy staffs aren't immune to the growing flame of chronic workplace stress. -
15 best pharmacy schools for first-time NAPLEX pass rates
About 120 students who took the North American Pharmacist Licensure Examination test at one California school in 2022 passed their first time, according to the National Association of Boards of Pharmacy. -
Canadian province slows Ozempic sales to US: 4 updates
Eleven days after the domestic Ozempic shortage partially ended, an official in British Columbia said March 28 the province is limiting how much of the Type 2 diabetes drug its online pharmacies can sell to U.S. and other non-Canadian residents. -
How an alleged monkey smuggling scheme can stifle drug research
The National Association for Biomedical Research and other medical groups are urging federal officials to help amid a shortage of monkeys they say is disrupting research for lifesaving medications. -
Arizona nixes physician prescription requirement for birth control
Arizona passed a bill which allows pharmacists to dispense birth control with non-patient specific orders, the Observer Today reported March 30. -
FDA panel sets date for OTC birth control meeting
On May 9 and May 10, an FDA advisory panel will discuss whether to recommend the agency approve what could be the first over-the-counter birth control pill.
Page 20 of 50